FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to conjugates of amatoxin and target-binding fragment, e.g. an antibody bound by certain bonds, applicable in treating cancer, and to pharmaceutical compositions containing these conjugates.
EFFECT: producing new compounds for treating cancer.
25 cl, 2 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AMATOXIN-CONJUGATES WITH IMPROVED LINKERS | 2011 |
|
RU2601411C2 |
| AMATOXIN DERIVATIVES | 2014 |
|
RU2695370C2 |
| AMATHOXINE-ANTIBODY CONJUGATES | 2016 |
|
RU2724328C2 |
| NEW METHOD FOR SYNTHESIS OF AMANITINES | 2018 |
|
RU2792210C2 |
| SYNTHESIS OF (S)-6-HYDROXYTRYPTOPHANE AND ITS DERIVATIVES | 2019 |
|
RU2810786C2 |
| ANTIBODY CONJUGATE WITH NON-NATURAL AMATOXIN | 2018 |
|
RU2798981C2 |
| DELIVERY SYSTEMS FOR CONTROLLED DRUG RELEASE | 2016 |
|
RU2748992C2 |
| SYNTHESIS METHODS OF AMATOXIN STRUCTURAL BLOCK AND AMATOXINS | 2013 |
|
RU2637924C2 |
| METHODS OF TREATING CANCER, HAVING HEMIZYGOUS LOSS OF TP53 | 2016 |
|
RU2721953C2 |
| COMPOSITIONS AND METHODS RELATING TO DRUG CONJUGATES WITH ANTI-CD19 ANTIBODIES | 2019 |
|
RU2806333C2 |
